These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5771897)

  • 21. Pulmonary Mycobacterium scrofulaceum infection in a child.
    Cooper AR; Martin RS
    Pediatrics; 1972 Jan; 49(1):118-24. PubMed ID: 5059291
    [No Abstract]   [Full Text] [Related]  

  • 22. Pulmonary fibrosis and group IV mycobacteria infection of the lungs in ankylosing spondylitis.
    Gacad G; Massaro D
    Am Rev Respir Dis; 1974 Feb; 109(2):274-8. PubMed ID: 4811782
    [No Abstract]   [Full Text] [Related]  

  • 23. [Isolation of atypical mycobacteria in the sputum of miners: clinical and epidemiologic aspects].
    Casula D
    Rev Tuberc Pneumol (Paris); 1970; 34(1):79-86. PubMed ID: 5517745
    [No Abstract]   [Full Text] [Related]  

  • 24. [Activity of Isoxyl on Mycobacterium kansasii; studies in vitro and in the pneumoconiotic guinea pig].
    Tacquet A; Devulder B; Tison F; Martin JC
    Antibiot Chemother; 1970; 16():160-76. PubMed ID: 5535612
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and bacteriologic evaluation of pulmonary mycobacterioses in the greater Boston area.
    Stottmeier KD; Tose L; Jones C
    Am Rev Respir Dis; 1973 Nov; 108(5):1227-30. PubMed ID: 4746582
    [No Abstract]   [Full Text] [Related]  

  • 26. Mycobacterium malmoense and underlying lung disease.
    McGrath EE; Bardsley P
    Eur J Intern Med; 2008 Nov; 19(7):e49-50. PubMed ID: 19013363
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical aspects of atypical mycobacterial infection.
    Kahana LM; Cole FM; Richardson H
    Can Med Assoc J; 1975 Feb; 112(3):321-4. PubMed ID: 1109749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental study of interactions between pneumoconiosis and mycobacterial infections.
    Gernez-Rieux C; Tacquet A; Devulder B; Voisin C; Tonnel A; Aerts C; Policard A; Martin JC; Le Bouffant L; Daniel H
    Ann N Y Acad Sci; 1972 Dec; 200():106-26. PubMed ID: 4350422
    [No Abstract]   [Full Text] [Related]  

  • 29. Nontuberculous mycobacterial infections of man.
    Wolinsky E
    Med Clin North Am; 1974 May; 58(3):639-48. PubMed ID: 4132589
    [No Abstract]   [Full Text] [Related]  

  • 30. Infections with atypical mycobacteria. Five years' experience at the National Jewish Hospital.
    Fischer DA; Lester W; Schaefer WB
    Am Rev Respir Dis; 1968 Jul; 98(1):29-34. PubMed ID: 5657150
    [No Abstract]   [Full Text] [Related]  

  • 31. Ofloxacin and the treatment of pulmonary disease due to Mycobacterium fortuitum.
    Ichiyama S; Tsukamura M
    Chest; 1987 Dec; 92(6):1110-2. PubMed ID: 3479304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection with the avian-Battey group of mycobacteria in England and Wales.
    Schaefer WB; Birn KJ; Jenkins PA; Marks J
    Br Med J; 1969 May; 2(5654):412-5. PubMed ID: 5813802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary lesions due to opportunist mycobacteria. (Review includes 30 cases of M. kansasii infections).
    Anderson DH; Grech P; Townshend RH; Jephcott AE
    Clin Radiol; 1975 Oct; 26(4):461-9. PubMed ID: 1201641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of Mycobacterium simiae in respiratory specimens.
    Samra Z; Kaufman L; Pitlik S; Shalit I; Bishara J
    Scand J Infect Dis; 2005; 37(11-12):838-41. PubMed ID: 16308217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology and clinical aspects of Mycobacterium infections. Mycobacterium fortuitum, kansasii and aquae IIc].
    Arzt GH; Lodenkämper H
    Med Klin; 1969 Nov; 64(47):2177-83. PubMed ID: 5359261
    [No Abstract]   [Full Text] [Related]  

  • 36. [Epidemiological and clinical studies in diseases with atypical mycobacteria].
    Schmiedel A
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):141-3. PubMed ID: 5632191
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary disease caused by Mycobacterium marseillense, Italy.
    Grottola A; Roversi P; Fabio A; Antenora F; Apice M; Tagliazucchi S; Gennari W; Serpini GF; Rumpianesi F; Fabbri LM; Magnani R; Pecorari M
    Emerg Infect Dis; 2014 Oct; 20(10):1769-70. PubMed ID: 25271594
    [No Abstract]   [Full Text] [Related]  

  • 38. An epidemiologic study of unclassified mycobacteria in Virginia.
    Gerszten E; Allison MJ; Dalton HP; Brummer DL
    South Med J; 1968 Mar; 61(3):275-7. PubMed ID: 5643620
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiological features of pulmonary atypical mycobacterial infections.
    Seibert CE; Tabrisky J
    Br J Radiol; 1969 Feb; 42(494):140-4. PubMed ID: 4975209
    [No Abstract]   [Full Text] [Related]  

  • 40. Background factors for casual isolation of Mycobacterium intracellulare from sputum of patients with tuberculosis.
    Tsukamura M
    Am Rev Respir Dis; 1973 Sep; 108(3):679-83. PubMed ID: 4200818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.